MS-GF+ statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.

Subscribe
info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Database search chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

MS-GF+ specifications

Information


Unique identifier OMICS_02525
Name MS-GF+
Software type Package/Module
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux
Programming languages Java
Computer skills Advanced
Stability Stable
Maintained Yes

Versioning


Add your version

Documentation


Maintainer


  • person_outline Pavel Pevzner <>

Publication for MS-GF+

MS-GF+ in publications

 (2)
PMCID: 4261978
PMID: 25301683
DOI: 10.1021/pr500812t

[…] to these sequences.,, a number of different programs have been used for matching of ms/ms data to these databases, including both publicly available programs such as x! tandem,,, myrimatch,,, and ms-gf+3 and commercial programs such as mascot, sequest, and proteinpilot. after identification of possible novel peptide sequences, a number of steps for filtering and assessing confidence […]

PMCID: 4223503
PMID: 25100859
DOI: 10.1074/mcp.O114.038877

[…] peptides during dda. they can probably be targeted and identified in experiments with a longer lc gradient, enhanced digestion, or with prefractionation. interestingly, replacing morpheus-as with ms-gf+percolator yielded 8% more unique peptides without increasing the number of psms. but our investigation showed that these extra peptides had a lower rate (66%) of mapping to confetti database. […]


To access a full list of publications, you will need to upgrade to our premium service.

MS-GF+ institution(s)
Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA, USA; Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Centre for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands; Netherlands Proteomics Centre, Utrecht, Netherlands; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
MS-GF+ funding source(s)
This work was supported by National Institutes of Health Grant 1-P41-RR024851 from the National Center for Research Resources.

MS-GF+ reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review MS-GF+